BRIEF published on 04/25/2025 at 07:05, 1 day 3 hours ago BB Biotech AG annonce une perte nette de 241 millions de francs suisses au premier trimestre 2025 Perte Nette Portefeuille D'investissement Développement De Médicaments BB Biotech Rapport Intermédiaire
BRIEF published on 04/25/2025 at 07:05, 1 day 3 hours ago BB Biotech AG Reports CHF 241 Million Net Loss for Q1 2025 Drug Development Net Loss Investment Portfolio Interim Report BB Biotech
BRIEF published on 04/25/2025 at 07:05, 1 day 3 hours ago BB Biotech T1 2025 : ajustements de portefeuille dans un contexte de marché volatil Volatilité Du Marché Portefeuille D'investissement BB Biotech Secteur Biotechnologique Approbations De La FDA
BRIEF published on 04/25/2025 at 07:05, 1 day 3 hours ago BB Biotech Q1 2025: Portfolio Adjustments Amid Volatile Market Market Volatility Investment Portfolio Biotech Sector BB Biotech FDA Approvals
PRESS RELEASE published on 04/25/2025 at 07:00, 1 day 3 hours ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125 Financial Results Investment Company BB Biotech AG Interim Report Business Activities
PRESS RELEASE published on 04/25/2025 at 07:00, 1 day 3 hours ago BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
BRIEF published on 03/19/2025 at 17:50, 1 month 6 days ago BB Biotech AG Shareholders Approve Dividend and Re-Elect Board Investment Strategy Dividend Board Re-election BB Biotech AGM 2025
BRIEF published on 03/19/2025 at 17:50, 1 month 6 days ago Les actionnaires de BB Biotech AG approuvent le dividende et réélisent le conseil d'administration Dividende Stratégie D'investissement Réélection Du Conseil D'administration BB Biotech Assemblée Générale Annuelle 2025
PRESS RELEASE published on 03/19/2025 at 17:45, 1 month 6 days ago Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share Shareholders at BB Biotech AG’s AGM approve dividend of CHF 1.80 per share and all board proposals. Re-elected board members for another term Shareholders Dividend AGM BB Biotech AG Board Proposals
BRIEF published on 02/21/2025 at 07:05, 2 months 5 days ago BB Biotech AG Releases 2024 Annual Report Dividend Proposal Net Profit BB Biotech AG Biotechnology Sector 2024 Annual Report
Published on 04/26/2025 at 02:00, 8 hours 44 minutes ago Battery X Metals Announces Strategic Agreement to Advance Artificial Intelligence-Driven Exploration of Critical Battery Metals in Nevada, USA
Published on 04/25/2025 at 23:30, 11 hours 14 minutes ago AIML Innovations Announces Departure of Tim Daniels from Board of Directors
Published on 04/25/2025 at 23:01, 11 hours 43 minutes ago Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024
Published on 04/25/2025 at 23:00, 11 hours 44 minutes ago AIML Optimizes Quantum Sciences Acquisition to Drive Growth & Strategic Focus
Published on 04/25/2025 at 22:15, 12 hours 29 minutes ago Grande Portage Resources Announces Extension of Expiry Date for Warrants
Published on 04/25/2025 at 22:47, 11 hours 56 minutes ago DEAG achieves new revenue level in “transformation year” 2024 – Strategic investments and strong start to the year create basis for future sustainable growth
Published on 04/25/2025 at 20:30, 14 hours 14 minutes ago EQS-Adhoc: Nagarro SE: Confirms 2024 guidance and dividend, postpones publication for full-year results
Published on 04/25/2025 at 18:44, 15 hours 59 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 04/25/2025 at 18:31, 16 hours 12 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/25/2025 at 18:30, 16 hours 13 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/26/2025 at 07:00, 3 hours 44 minutes ago Groupe DLSI - Chiffre d'affaires 1er trimestre 2025
Published on 04/25/2025 at 18:05, 16 hours 38 minutes ago Chiffre d’affaires du premier trimestre 2025
Published on 04/25/2025 at 18:05, 16 hours 38 minutes ago Louis Hachette Group - Chiffre d'affaires du 1e trimestre 2025
